IP Library Granted Patent US 6,924,382
Granted Patent B2
US 6,924,382 · App. 10/431,318 · Granted Aug 2, 2005

Rumen bypass calcium salts of C18:1 and C18:2 fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,924,382
App. No.
10/431,318
Granted
Aug 2, 2005
Kind
B2
Abstract

Free-flowing unsaturated fatty acid calcium salts containing from about 0.1 to about 1.5 equivalents of calcium hydroxide relative to the fatty acid content, with the fatty acid content consisting essentially of (a) from about 40 to about 95% percent by weight of unsaturated C:16-C:22 fatty acids; (b) from about 5 to about 60% by weight of saturated C:14-C:22 fatty acids; and (c) no more than about 6% by weight of moisture, insolubles and unsaponifiables; with no more than about 20% by weight being in for form of glycerides; wherein from about 40 to about 65% by weight of the total product weight consists of trans-C18:1 and C18:2 fatty acids; provided that when less than 0.75 equivalents of calcium hydroxide is present, the fatty acid content is at least 25% by weight saturated fatty acids.

Claims (5)

1. A free-flowing unsaturated fatty acid calcium salt comprising from about 0.1 to about 1.5 equivalents of calcium hydroxide relative to the fatty acid content, said fatty acid content consisting essentially of:

(a) from about 40 to about 95% percent by weight of unsaturated C:16-C:22 fatty acids; (b) from about 5 to about 60% by weight of saturated C:14-C:22 fatty acids; and (c) no more than about 6% by weight of moisture, insolubles and unsaponifiables; with no more than about 20% by weight being in the form of glycerides;

wherein from about 40 to about 65% by weight of the total product weight consists of trans-C18:1 and C18:2 fatty acids; provided that when less than 0.75 equivalents of calcium hydroxide is present, said fatty acid content is at least 25% by weight saturated fatty acids.

2. The fatty acid calcium salt of claim 1 , wherein the ratio of trans-C18:1 and C18:2 fatty acids is between about 60 and about 80% by weight of trans-C18:1 fatty acids to between about 20 and about 40% by weight of C18:2 fatty acids.

3. The fatty acid calcium salt of claim 2 , wherein the ratio of trans-C18:1 and C18:2 fatty acids is between about 65 and about 75% by weight of trans-C18:1 fatty acids to between about 25 and about 35% by weight of C18:2 fatty acids.

Assignments (5)
SECURITY INTEREST Recorded Apr 11, 2019
From: VIRTUS NUTRITION, LLC
To: CITY NATIONAL BANK
Reel/Frame 048865/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2005
From: NOREL ACQUISITION CORPORATION
To: VIRTUS NUTRITION LLC
Reel/Frame 016275/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2004
From: STROHMAIER, GEORGE K.; LUCHINI, NESTOR D.
To: NOREL ACQUISITION CORP.
Reel/Frame 014925/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2004
From: FREDERIKSEN, EILER D.
To: ESMAH, INC.
Reel/Frame 014884/0424 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2004
From: ESMAH, INC.
To: NOREL ACQUISITION CORPORATION
Reel/Frame 014884/0427 →